Risk Factors for RSV Hospitalization in Healthy Preterm Infants: A Meta-analysis

Pediatr Infect Dis J. 2017 Jul;36(7):696. doi: 10.1097/INF.0000000000001559.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antiviral Agents
  • Gestational Age
  • Hospitalization
  • Humans
  • Infant
  • Infant, Newborn
  • Infant, Premature*
  • Palivizumab*
  • Respiratory Syncytial Virus Infections
  • Risk Factors

Substances

  • Antiviral Agents
  • Palivizumab